• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒被F蛋白和G蛋白单克隆抗体单独及混合中和的情况。

Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.

作者信息

Anderson L J, Bingham P, Hierholzer J C

机构信息

Division of Viral Diseases, Centers for Disease Control, Atlanta, Georgia 30333.

出版信息

J Virol. 1988 Nov;62(11):4232-8. doi: 10.1128/JVI.62.11.4232-4238.1988.

DOI:10.1128/JVI.62.11.4232-4238.1988
PMID:2459412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC253856/
Abstract

We identified several types of neutralization effected by F and G protein monoclonal antibodies (MAbs) reacted individually or as mixtures against respiratory syncytial virus (RSV). Neutralizing activity was identified by a microneutralization test in which virus replication was determined by enzyme immunoassay. Complete neutralization was seen only with MAbs against the F protein. Strain-specific neutralization, complete neutralization against some strains of RSV, and no neutralization against other strains were seen with an additional MAb against the F protein. Partial neutralization, virus replication significantly reduced but still present, and no neutralization were seen with MAbs against both the F and G proteins. Enhanced neutralization, enhanced efficacy of neutralization, or increased neutralizing titer with a mixture of two MAbs over that for the individual MAbs was seen with all MAbs against the F protein and all but three MAbs against the G protein. Most (10 of 13) of the MAbs that exhibited neutralizing activity reacted with some but not all strains of RSV in an enzyme immunoassay. The epitopes corresponding to these 10 MAbs probably contribute to the strain-specific component of the neutralizing antibody response to RSV. Our results suggest that interpretation of RSV neutralization with MAbs is complex and that studies of such neutralization should include mixtures of MAbs and multiple RSV strains.

摘要

我们鉴定了F蛋白和G蛋白单克隆抗体(MAb)单独或混合作用于呼吸道合胞病毒(RSV)时产生的几种中和作用类型。通过微量中和试验鉴定中和活性,其中通过酶免疫测定法测定病毒复制情况。仅针对F蛋白的单克隆抗体可实现完全中和。针对F蛋白的另一单克隆抗体可观察到毒株特异性中和作用,即对某些RSV毒株完全中和,而对其他毒株无中和作用。针对F蛋白和G蛋白的单克隆抗体可观察到部分中和作用,即病毒复制显著减少但仍存在,以及无中和作用。针对F蛋白的所有单克隆抗体以及针对G蛋白的除三种以外的所有单克隆抗体,与单独使用单克隆抗体相比,两种单克隆抗体混合物的中和作用增强、中和效力增强或中和效价增加。在酶免疫测定中,大多数(13种中的10种)表现出中和活性的单克隆抗体与部分而非全部RSV毒株发生反应。与这10种单克隆抗体相对应的表位可能构成了针对RSV的中和抗体反应的毒株特异性成分。我们的结果表明,用单克隆抗体解释RSV中和作用很复杂,此类中和作用的研究应包括单克隆抗体混合物和多种RSV毒株。

相似文献

1
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.呼吸道合胞病毒被F蛋白和G蛋白单克隆抗体单独及混合中和的情况。
J Virol. 1988 Nov;62(11):4232-8. doi: 10.1128/JVI.62.11.4232-4238.1988.
2
Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.呼吸道合胞病毒融合蛋白上被鼠源和牛源单克隆抗体识别的保护性表位。
J Gen Virol. 1992 Sep;73 ( Pt 9):2217-23. doi: 10.1099/0022-1317-73-9-2217.
3
Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.亚型特异性呼吸道合胞病毒附着蛋白抗原位点的比较
J Gen Virol. 1989 Nov;70 ( Pt 11):2953-61. doi: 10.1099/0022-1317-70-11-2953.
4
Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein.呼吸道合胞病毒融合蛋白构象受限保护性表位的肽模拟物。
Immunol Lett. 1997 Jun 1;57(1-3):15-7. doi: 10.1016/s0165-2478(97)00045-x.
5
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.针对人呼吸道合胞病毒融合糖蛋白的中和性单克隆抗体所识别的两个抗原位点的特性分析
J Gen Virol. 1992 Sep;73 ( Pt 9):2225-34. doi: 10.1099/0022-1317-73-9-2225.
6
Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.利用合成肽定位呼吸道合胞病毒融合蛋白上的中和抗原结构域。
J Gen Virol. 1991 May;72 ( Pt 5):1051-8. doi: 10.1099/0022-1317-72-5-1051.
7
Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.用抗独特型抗体诱导对人呼吸道合胞病毒的中和免疫反应。
J Virol. 1990 Sep;64(9):4199-206. doi: 10.1128/JVI.64.9.4199-4206.1990.
8
Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.与呼吸道合胞病毒(RSV)F蛋白对应的合成肽可刺激小鼠B细胞和T细胞,但无法提供保护作用。
Arch Virol. 1991;117(1-2):59-71. doi: 10.1007/BF01310492.
9
Analysis of the bovine respiratory syncytial virus fusion protein (F) using monoclonal antibodies.使用单克隆抗体对牛呼吸道合胞病毒融合蛋白(F)进行分析。
Vet Microbiol. 1997 Nov;58(2-4):175-85. doi: 10.1016/s0378-1135(97)00171-5.
10
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.用单克隆抗体对呼吸道合胞病毒株进行抗原特性分析。
J Infect Dis. 1985 Apr;151(4):626-33. doi: 10.1093/infdis/151.4.626.

引用本文的文献

1
Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection.老年人接种疫苗或感染后呼吸道合胞病毒的体液抗体反应
J Infect Dis. 2025 Jul 11;231(6):e1146-e1150. doi: 10.1093/infdis/jiaf149.
2
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F protein.一种针对 RSV F 蛋白前融合保守区域的强效广谱中和抗体。
Nat Commun. 2024 Nov 21;15(1):10085. doi: 10.1038/s41467-024-54384-x.
3
Global progress in clinical research on human respiratory syncytial virus vaccines.全球人类呼吸道合胞病毒疫苗临床研究进展。
Front Microbiol. 2024 Sep 2;15:1457703. doi: 10.3389/fmicb.2024.1457703. eCollection 2024.
4
Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins.系统性计算机辅助二硫键设计作为稳定I类前融合融合蛋白的通用策略。
Front Immunol. 2024 Jul 24;15:1406929. doi: 10.3389/fimmu.2024.1406929. eCollection 2024.
5
Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.鼻腔内接种展示 G 蛋白保守区的呼吸道合胞病毒样颗粒的疫苗,在受到野生型呼吸道合胞病毒攻击时会引起严重的体重减轻和病理变化。
Viruses. 2024 May 24;16(6):843. doi: 10.3390/v16060843.
6
A general computational design strategy for stabilizing viral class I fusion proteins.一种稳定病毒 I 类融合蛋白的通用计算设计策略。
Nat Commun. 2024 Feb 13;15(1):1335. doi: 10.1038/s41467-024-45480-z.
7
Recent advances in the prevention of respiratory syncytial virus in pediatrics.儿科呼吸道合胞病毒预防的最新进展。
Curr Opin Pediatr. 2024 Apr 1;36(2):182-189. doi: 10.1097/MOP.0000000000001336. Epub 2024 Jan 30.
8
Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection.表达呼吸道合胞病毒预融合蛋白和G蛋白的病毒样颗粒疫苗可提供针对呼吸道合胞病毒攻击感染的保护。
Pharmaceutics. 2023 Feb 27;15(3):782. doi: 10.3390/pharmaceutics15030782.
9
The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein.为老年人研发呼吸道合胞病毒疫苗的探索:超越融合蛋白的思考
Vaccines (Basel). 2023 Feb 7;11(2):382. doi: 10.3390/vaccines11020382.
10
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.呼吸道合胞病毒(RSV)G 蛋白增强包膜病毒样颗粒疫苗候选物中 RSV F 蛋白的免疫应答。
J Virol. 2023 Jan 31;97(1):e0190022. doi: 10.1128/jvi.01900-22. Epub 2023 Jan 5.

本文引用的文献

1
Antigenic differences between two strains of respiratory syncytial virus.两种呼吸道合胞病毒株之间的抗原差异。
Proc Soc Exp Biol Med. 1963 Apr;112:958-64. doi: 10.3181/00379727-112-28221.
2
Experimental infection with respiratory syncytial virus in several species of animals.几种动物呼吸道合胞病毒的实验性感染
Am J Hyg. 1962 Nov;76:302-12. doi: 10.1093/oxfordjournals.aje.a120285.
3
Epidemic bronchiolitis caused by a respiratory syncytial virus: clinical aspects.呼吸道合胞病毒引起的流行性细支气管炎:临床特征
Med J Aust. 1961 Dec 9;48(2):933-5. doi: 10.5694/j.1326-5377.1961.tb70132.x.
4
Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children.感染与黑猩猩鼻咽炎病原体(CCA)相关病毒的呼吸道疾病婴儿的康复情况。II. 婴幼儿感染的流行病学方面
Am J Hyg. 1957 Nov;66(3):291-300. doi: 10.1093/oxfordjournals.aje.a119902.
5
Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections.
J Med Virol. 1980;5(2):161-70. doi: 10.1002/jmv.1890050210.
6
Maternal antibody and respiratory syncytial virus infection in infancy.婴儿期的母源抗体与呼吸道合胞病毒感染
J Med Virol. 1981;7(4):263-71. doi: 10.1002/jmv.1890070403.
7
Classification of hybridomas to respiratory syncytial virus glycoproteins.针对呼吸道合胞病毒糖蛋白的杂交瘤分类
Proc Soc Exp Biol Med. 1982 Dec;171(3):266-71. doi: 10.3181/00379727-171-41509.
8
Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.呼吸道合胞病毒包膜糖蛋白之一GP90的纯化与特性分析
J Gen Virol. 1984 Apr;65 ( Pt 4):761-7. doi: 10.1099/0022-1317-65-4-761.
9
Cellular and humoral immunity in recurrent respiratory syncytial virus infections.复发性呼吸道合胞病毒感染中的细胞免疫和体液免疫
Pediatr Res. 1983 Sep;17(9):753-8. doi: 10.1203/00006450-198309000-00014.
10
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.针对呼吸道合胞病毒蛋白的单克隆抗体:融合蛋白的鉴定
J Virol. 1983 Jul;47(1):171-7. doi: 10.1128/JVI.47.1.171-177.1983.